GB0205327D0 - compounds - Google Patents

compounds

Info

Publication number
GB0205327D0
GB0205327D0 GBGB0205327.0A GB0205327A GB0205327D0 GB 0205327 D0 GB0205327 D0 GB 0205327D0 GB 0205327 A GB0205327 A GB 0205327A GB 0205327 D0 GB0205327 D0 GB 0205327D0
Authority
GB
United Kingdom
Prior art keywords
compounds
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0205327.0A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB0205327.0A priority Critical patent/GB0205327D0/en
Publication of GB0205327D0 publication Critical patent/GB0205327D0/en
Priority to JP2003573005A priority patent/JP2005519119A/ja
Priority to ES03708328T priority patent/ES2250874T3/es
Priority to US10/506,339 priority patent/US7354966B2/en
Priority to EP03708328A priority patent/EP1480990B1/en
Priority to AT03708328T priority patent/ATE309253T1/de
Priority to DE60302222T priority patent/DE60302222T2/de
Priority to PCT/GB2003/000876 priority patent/WO2003074537A1/en
Priority to AU2003212509A priority patent/AU2003212509A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
GBGB0205327.0A 2002-03-06 2002-03-06 compounds Ceased GB0205327D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0205327.0A GB0205327D0 (en) 2002-03-06 2002-03-06 compounds
JP2003573005A JP2005519119A (ja) 2002-03-06 2003-03-04 界面活性剤として使用するための化合物
ES03708328T ES2250874T3 (es) 2002-03-06 2003-03-04 Compuestos para uso com tensioactivos.
US10/506,339 US7354966B2 (en) 2002-03-06 2003-03-04 Compounds for use as surfactants
EP03708328A EP1480990B1 (en) 2002-03-06 2003-03-04 Compounds for use as surfactants
AT03708328T ATE309253T1 (de) 2002-03-06 2003-03-04 Verbindungen zur verwendung als surfactanten
DE60302222T DE60302222T2 (de) 2002-03-06 2003-03-04 Verbindungen zur verwendung als surfactanten
PCT/GB2003/000876 WO2003074537A1 (en) 2002-03-06 2003-03-04 Compounds for use as surfactants
AU2003212509A AU2003212509A1 (en) 2002-03-06 2003-03-04 Compounds for use as surfactants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0205327.0A GB0205327D0 (en) 2002-03-06 2002-03-06 compounds

Publications (1)

Publication Number Publication Date
GB0205327D0 true GB0205327D0 (en) 2002-04-17

Family

ID=9932460

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0205327.0A Ceased GB0205327D0 (en) 2002-03-06 2002-03-06 compounds

Country Status (9)

Country Link
US (1) US7354966B2 (https=)
EP (1) EP1480990B1 (https=)
JP (1) JP2005519119A (https=)
AT (1) ATE309253T1 (https=)
AU (1) AU2003212509A1 (https=)
DE (1) DE60302222T2 (https=)
ES (1) ES2250874T3 (https=)
GB (1) GB0205327D0 (https=)
WO (1) WO2003074537A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011038872A1 (en) * 2009-10-02 2011-04-07 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol formulations of formoterol and beclometasone dipropionate
GB201205632D0 (en) * 2012-03-30 2012-05-16 Vectura Ltd Method and apparatus

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4352789A (en) 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
NZ222907A (en) * 1986-12-16 1990-08-28 Novo Industri As Preparation for intranasal administration containing a phospholipid absorption enhancing system
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
JPH02273536A (ja) * 1989-04-13 1990-11-08 Yakult Honsha Co Ltd 界面活性剤およびその製造法
EP0478686B1 (en) * 1989-06-22 1993-08-11 Applications Et Transferts De Technologies Avancees Atta Fluorine and phosphorous-containing amphiphilic molecules with surfactant properties
GB8921222D0 (en) 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
IL97065A (en) 1990-02-02 1994-01-25 Fisons Plc Repellent preparations for aerosol
DE4003272A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
DE69131867T2 (de) 1990-03-23 2000-05-18 Minnesota Mining And Mfg. Co., Saint Paul Anwendung von löslichen fluorhaltigen Tensiden zur Herstellung von Aerosol-Präparaten mit dosierter Abgabe
AU650463B2 (en) 1990-06-27 1994-06-23 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5126123A (en) 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
WO1992000061A1 (en) * 1990-06-29 1992-01-09 Fisons Plc Pressurised aerosol compositions
US5376359A (en) 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
HU219900B (hu) 1995-04-14 2001-09-28 Glaxo Wellcome Inc. Mért dózist adagoló inhalálóberendezés
DK0880530T3 (da) * 1996-02-16 2003-10-27 Max Planck Gesellschaft Phosphatidyloligoglyceroler
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0118364D0 (en) * 2001-07-27 2001-09-19 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
EP1480990B1 (en) 2005-11-09
US20050287076A1 (en) 2005-12-29
WO2003074537A1 (en) 2003-09-12
US7354966B2 (en) 2008-04-08
DE60302222D1 (de) 2005-12-15
ES2250874T3 (es) 2006-04-16
JP2005519119A (ja) 2005-06-30
ATE309253T1 (de) 2005-11-15
EP1480990A1 (en) 2004-12-01
DE60302222T2 (de) 2006-06-01
AU2003212509A1 (en) 2003-09-16

Similar Documents

Publication Publication Date Title
PL372926A1 (en) Piperidine-pyridazones and phthalazones as pde4 inhibitors
PL369530A1 (en) Chemical compounds
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
DE60310576D1 (en) 2-hydroxy-6-phenylphenanthridine als pde-4-hemmer
TNSN07235A1 (en) Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
IL163777A0 (en) Kinase inhibitors
SG145694A1 (en) Novel compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
JO2654B1 (en) Multiple aryl caroxa amides are useful as lipid - lowering agents
AU2003228770A1 (en) Substituted pyrazolopyrimidines
GB0127903D0 (en) Improvements relating to organic compounds
MXPA04003886A (es) Tiofen- y tiazolsulfonamidas como agentes antineoplasticos.
AU2003290592A1 (en) Antitumor benzoylsulfonamides
ZA200404752B (en) 6-aminomorphinane derivatives method for the production and use thereof
GEP20074215B (en) Novel method for the industrial synthesis of strontium ranelate and the hydrates thereof
SE0103710D0 (sv) Compounds
PT1419163E (pt) Imidazopiridinas triciclicas
MXPA04003755A (es) Endoprotesis vasculares.
MXPA03003942A (es) Compuestos bis-heterociclicos con actividad antitumoral y quimiosensibilizante.
PL377176A1 (pl) N-Sulfonylo-4-metylenoamino-3-hydroksy-2-pirydony
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
SI1377574T1 (https=)
DE602004012146D1 (en) Pyrazolopyrimidine
MXPA06000372A (es) Compuestos de silicio y su uso.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)